Chart Advisor: Tapering to Begin


Visit: Investopedia

Wednesday, 3rd November, 2021

1/ Indexes closed higher even as Fed announces tapering 

2/ CVS beats estimates, raises guidance 

3Traders buying call options before earnings

4/ The bottom line

1/ Indexes Closed Higher Even as Fed Announces Tapering 

Stocks moved higher after the Federal Reserve announced it will soon start to reduce its monthly bond purchases. Tapering of the current $120 billion per month of bond purchases is the first step in reducing the massive amount of aid the central bank has provided markets and the economy to spur economic recovery of the COVID-19 pandemic.  

The chart below compares State Street’s S&P 500 Index ETF (SPY) with iShares’ 20+ Year Treasury Bond ETF (TLT). Stocks and bonds tend to have an inverse relationship as higher-yield bonds make for an attractive investment, so investors may sell stocks in favor of bonds. However, this happens more often during times of economic recession, when consumer spending drives down corporate profits and lower-risk bonds appear more attractive.  

This chart illustrates exactly when the Federal Reserve released their statements on Wednesday. Investors sold off bonds and piled into stocks, as the tapering of bond purchases, coupled with relatively strong earnings overall for the third quarter, indicates a healthy economy. 

An analyst might normally expect that news like this from the Fed would dampen investor enthusiasm for stocks. Investors instead bought more shares, showing a vote of confidence for the Fed’s decision. 

2/ CVS Beats Estimates, Raises Guidance 

Investors bid up the share prices of CVS Health Corporation (CVS) after the company exceeded expectations for the fiscal third quarter. Analysts forecast CVS to announce $1.78 in earnings per share (EPS) and $70.49 billion in revenue. CVS reported $1.97 in EPS and $73.79 billion in revenue, receiving a boost as consumers came to stores for COVID-19 tests and vaccines. CVS also raised its full-year outlook. CVS shares surged more than 5%. 

CVS has recently moved ahead of its sector, as illustrated on the chart below, which compares the recent performance of CVS with State Street’s Healthcare Sector ETF (XLV). CVS’ recent upward trend shows that investors were anticipating a positive earnings result. The company had recently been in line with XLV coming out of September. Over the last year, XLV has gained 27% while CVS has added 61%. 

Option traders could be anticipating CVS shares to continue rising in the near term, as the stock did after its earnings report last quarter. Option trading volumes on Wednesday favored call options over puts more than 7-to-1. 

3/ Traders Buying Call Options Before Earnings 

Optimism appears to be growing toward the third-quarter earnings of Uber Technologies (UBER). Investors bid up the share prices 6%, one day before the company is expected to announce results for the quarter. Analysts expect the ride-sharing giant to report a net loss per share of $0.31 and $4.5 billion in revenue. 

Option traders appear to be positioned for the stock to rise in the near term, as the open interest for UBER shows over 1.6 million call options against 1.1 million puts. Trading volumes on Wednesday favored calls over puts more than 4-to-1.

Despite the skew toward call options, puts remain slightly higher priced after accounting for intrinsic value. This could mean that option traders are taking the opportunity to sell call options while premiums are unusually high before earnings. 

Option traders and investors could be anticipating similar post-earnings moves for UBER as for competitor Lyft (LYFT), which rose 9% the day after reporting better-than-expected earnings and revenues for the third quarter.     

4/ The Bottom Line 

Stocks moved higher after the Fed announced it would begin tapering its bond purchases later this month. Investors considered it good news, buying up stocks such as CVS and UBER. CVS turned in a good report today, and Uber reports tomorrow. 

Originally posted on 3rd November, 2021

Disclosure: Investopedia The comments, opinions and analyses expressed herein are for informational purposes only and should not be considered individual investment advice or recommendations to invest in any security or to adopt any investment strategy.  While we believe the information provided herein is reliable, we do not warrant its accuracy or completeness. The views and strategies described on our content may not be suitable for all investors. Because market and economic conditions are subject to rapid change, all comments, opinions and analyses contained within our content are rendered as of the date of the posting and may change without notice. The material is not intended as a complete analysis of every material fact regarding any country, region, market, industry, investment or strategy. This information is intended for US residents only.

Disclosure: Interactive Brokers

Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from Investopedia and is being posted with permission from Investopedia. The views expressed in this material are solely those of the author and/or Investopedia and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

In accordance with EU regulation: The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.

Any trading symbols displayed are for illustrative purposes only and are not intended to portray recommendations.

Disclosure: Options Trading

Options involve risk and are not suitable for all investors. For more information read the Characteristics and Risks of Standardized Options, also known as the options disclosure document (ODD). To receive a copy of the ODD call 312-542-6901 or copy and paste this link into your browser: